Bedside Snapshot
- Normal Result
- Negative on the strip (below its detection limit, which varies by brand). A low-level positive can be normal in pregnancy.
- Significant Result
- Any positive dipstick, typically about 100 mg/dL (5.6 mmol/L) or more, when no SGLT2 inhibitor is taken
- Positive Suggests
- Serum glucose above about 180 mg/dL (diabetes, stress hyperglycemia)
- SGLT2 inhibitor use (expected effect)
- Renal glucosuria or Fanconi syndrome if serum glucose is normal
- Pregnancy, trace only (usually physiologic)
- Negative Does Not Exclude
- Diabetes, prediabetes or hyperglycemia below the renal threshold. Urine cannot detect hypoglycemia; check serum glucose.
- Act Now If
- Altered mentation, seizure or suspected hypoglycemia: check blood glucose now and treat per protocol. Glucosuria with vomiting or Kussmaul breathing: check blood glucose and ketones now.
- Watch Out For
- Expected glucosuria on an SGLT2 inhibitor does not mean hyperglycemia, and ketoacidosis can occur with near-normal glucose on these drugs.
Reference & Critical Ranges
Lab-specific ranges: Your lab sets the range. Reference intervals vary by laboratory, analyzer and population. Read the range on your own report. The values below are typical only.
Reference ranges
| Population | Conventional | SI | Notes |
|---|---|---|---|
| Adults (non-pregnant) | Negative (below the strip's detection limit) | Negative | Dipstick. Quantitative lab methods use the lab's own range |
| Pregnancy | Negative to trace | Not separately defined | Trace glucosuria can occur with normal serum glucose |
| Children | Same as adult | Same as adult | Persistent glucosuria with normal serum glucose needs tubular evaluation |
Severity and dipstick grades
| Result grade | Approximate concentration | SI (approx.) | What it means |
|---|---|---|---|
| Negative | Below the strip's detection limit (brand-specific) | Negative | Normal |
| Lowest positive band | About 100 mg/dL on some strips (labelled trace or 1+ depending on the strip) | About 5.6 mmol/L | Small amount. Can be physiologic in pregnancy. Check serum glucose if heavier, persistent or unexplained |
| Higher bands | 250, 500, 1,000 and 2,000 mg/dL on some strips (about 13.9, 27.8, 55.5 and 111 mmol/L) | Varies | Glucosuria. Serum glucose is usually above the renal threshold unless an SGLT2 inhibitor or tubular disease is present. Check serum glucose now if the result is large or the patient is unwell |
Conversion: mg/dL × 0.0555 = mmol/L
Causes of Abnormal Results
Positive result (glucosuria)
| Cause | Clue |
|---|---|
| Hyperglycemia above the renal threshold: diabetes mellitus (type 1 or type 2) | Serum glucose usually above about 180 mg/dL; polyuria, polydipsia, weight loss. Watch for hyperglycemic crisis (DKA, HHS) |
| Stress hyperglycemia: sepsis, acute MI, stroke, trauma, burns | Glucosuria with no known diabetes; check serum glucose and the acute illness |
| Other endocrine causes: Cushing syndrome, hyperthyroidism, pheochromocytoma | Glucosuria with the clinical features of the endocrine disorder |
| Drugs that raise serum glucose: corticosteroids, thiazide diuretics | Medication list; serum glucose above baseline |
| SGLT2 inhibitors: empagliflozin, dapagliflozin, canagliflozin, ertugliflozin, sotagliflozin, bexagliflozin (expected effect) | Glucosuria with normal or near-normal serum glucose; confirm with the medication list |
| Renal glucosuria (familial): isolated proximal reabsorption defect, usually benign | Normal serum glucose; no other tubular abnormality |
| Proximal tubular dysfunction: Fanconi syndrome (cystinosis, Wilson disease, multiple myeloma, heavy metals, drugs such as ifosfamide); recovery from acute tubular necrosis | Normal serum glucose plus proteinuria, aminoaciduria, phosphaturia or metabolic acidosis |
| Pregnancy: lower renal threshold and higher GFR | Low-level glucosuria with normal serum glucose. Heavier or persistent glucosuria needs a serum glucose check |
Glucose in urine with normal serum glucose: Start with the medication list. Is the patient on an SGLT2 inhibitor? If not, work up renal glucosuria or tubular dysfunction. Benign is a conclusion, not a starting point: don't use the word until tubular function is checked, especially with proteinuria or other abnormalities.
False positive vs true positive
| Cause | Clue |
|---|---|
| Oxidant contamination of the specimen or container (peroxide, detergent, disinfectant residue) | Unexplained positive in a patient with normal serum glucose. Recollect in a clean, dry container |
Interpretation & Bedside Approach
Step-by-step approach
- Is it real? Confirm a fresh or refrigerated specimen and a strip read at the time stated on the strip insert.
- How sick is the patient? Check alertness, breathing, volume status and fingerstick glucose. Urine glucose does not detect low blood glucose.
- Context: Known diabetes, insulin or sulfonylurea use, SGLT2 inhibitor use, pregnancy, corticosteroid or thiazide use.
- Serum glucose: Glucosuria with serum glucose above about 180 mg/dL suggests hyperglycemia. Normal serum glucose points to an SGLT2 inhibitor, renal glucosuria or tubular dysfunction.
- Tubular screen: If serum glucose is normal and glucosuria persists, check urine protein, serum creatinine and electrolytes (potassium, phosphate, bicarbonate) for Fanconi syndrome.
- Escalate or dispose: Hyperglycemia with vomiting, abdominal pain, confusion or Kussmaul breathing needs serum glucose, ketones and a blood gas now.
Diabetes diagnostic thresholds (for context)
| Test | Diabetes | Prediabetes |
|---|---|---|
| Fasting plasma glucose | ≥126 mg/dL (≥7.0 mmol/L) | 100–125 mg/dL (5.6–6.9 mmol/L) |
| 2-h OGTT (75 g) | ≥200 mg/dL (≥11.1 mmol/L) | 140–199 mg/dL (7.8–11.0 mmol/L) |
| HbA1c | ≥6.5% (≥48 mmol/mol) | 5.7–6.4% (39–47 mmol/mol) |
| Random plasma glucose | ≥200 mg/dL with classic symptoms | Not used |
Plasma glucose or HbA1c makes the diagnosis. Urine glucose doesn't (ADA Standards of Care, Section 2).
When urine glucose is useful
- Bedside flag: a prompt that serum glucose may be high until a real glucose result is back (not a diagnosis)
- SGLT2 inhibitor therapy: confirms the glucosuria the drug is meant to cause
- Tubular screen: part of a workup with urine protein and electrolytes when Fanconi syndrome or renal glucosuria is suspected
Limitations
- Insensitive: it sees only glucose above the renal threshold (about 160–200 mg/dL, with about 180 used here). Mild hyperglycemia slips through
- No hypoglycemia detection: urine glucose can't pick up low blood glucose
- Lagging: it shows glucose that reached the urine over the previous hours, not the serum glucose right now
- Not a diabetes test: it isn't used for diagnosis or monitoring. Use plasma glucose, HbA1c or fingerstick glucose
Special Populations
| Population | What changes | Clinical implication |
|---|---|---|
| Children & adolescents | Renal glucosuria is familial and usually benign | Persistent glucosuria with normal serum glucose: evaluate tubular function before reassurance |
| Pregnancy | Renal threshold is lower and GFR is higher | Trace glucosuria with normal serum glucose can be physiologic. Heavier or persistent glucosuria warrants a serum glucose check. Gestational diabetes is screened with a glucose test, not urine glucose |
| Older adults | SGLT2 inhibitor glucosuria adds osmotic diuresis | Watch for volume depletion; record intake and orthostatic symptoms with SGLT2 inhibitor therapy |
| CKD / reduced eGFR | SGLT2 inhibitor glucose-lowering effect diminishes as eGFR falls | Glucosuria may be smaller than expected; interpret with serum glucose and renal function |
| Liver disease | No clinically meaningful difference for this test | Interpret as in the general adult population |
Interfering Factors & Pitfalls
Collection and handling
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Delayed testing at room temperature | ↓ False − | Bacteria consume glucose (glycolysis) | Test promptly or refrigerate; record collection time |
| Contaminated container (detergent, disinfectant, bleach) | ↑ False + | Oxidant residue reacts with strip chemistry | Use a clean, dry container; recollect if suspicious |
| Strip read outside the stated window | ↑ or ↓ | Color develops and fades over time | Read at the time stated on the strip insert |
Medications and supplements
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| High-dose vitamin C (ascorbic acid) | ↓ False − | Interferes with the strip color reaction; effect varies by brand | If hyperglycemia is still suspected, check serum glucose; note the strip brand |
| SGLT2 inhibitors | Expected glucosuria (not interference) | Intended pharmacologic effect | Do not report as hyperglycemia; use serum glucose |
Physiologic and assay factors
| Factor | Effect | Why | Avoid / fix |
|---|---|---|---|
| Concentrated urine (high specific gravity) | ↓ False − | Can interfere with color development | Repeat on a fresh specimen if suspicion is high |
| Strip brand and lot differences | Varies | Chemistry and reading bands differ | Use the lab's chart; do not compare bands across brands |
Common misinterpretations
- A positive dip doesn't mean current hyperglycemia if the patient takes an SGLT2 inhibitor
- A negative dip doesn't rule out hyperglycemia, prediabetes or diabetes
- Trace glucosuria in pregnancy isn't gestational diabetes on its own
- Glucose in urine says nothing about hypoglycemia
Physiology & Test Basics
What it measures
Urine glucose is the glucose excreted in urine, usually reported as a dipstick grade. What does a positive or negative result say about serum glucose and renal tubular function? That's what this page covers. Ketones and protein have their own pages.
Physiology & regulation
- The glomerulus filters glucose freely.
- The early proximal tubule takes back about 90% of filtered glucose. SGLT2 does that work. SGLT1 takes up most of the rest.
- Reabsorption has a capacity limit. Push the filtered load past it and glucose spills into urine. That tipping point is the renal threshold: about 180 mg/dL (10 mmol/L), with individual values roughly 160–200 mg/dL.
- In pregnancy the renal threshold drops, because GFR rises.
- SGLT2 inhibitors block this reabsorption on purpose. Glucosuria is the intended effect.
How it is measured
Collect a random or timed clean-catch sample in a clean, dry container. Dip the strip fully and read it at the time the strip insert states. Dipstick glucose is semi-quantitative and gives an answer right at the bedside. Strip chemistry and bands differ by manufacturer. The lab's quantitative urine glucose is rarely needed for patient care.
Why it matters
A positive urine glucose is not a blood sugar. In emergency and critical care it's your cue to check serum glucose, not a result to act on by itself. It matters most in two cases: hyperglycemia during acute illness, and confirming SGLT2 inhibitor therapy.
Clinical Pearls
Working threshold, not a fixed cutoff: Glucosuria usually means serum glucose is above about 180 mg/dL. The real threshold sits roughly within 160–200 mg/dL. Check serum glucose before you decide what the result means.
Not a diabetes test: Diagnosis takes plasma glucose or HbA1c. At the bedside, the fingerstick is the test. Urine glucose can't show current glucose or hypoglycemia.
SGLT2 inhibitors and ketoacidosis: Ketoacidosis can show up with near-normal glucose on SGLT2 inhibitors (class warning, see the empagliflozin, sotagliflozin and bexagliflozin labels in References). Here's the catch: a positive urine glucose is expected on these drugs, and it doesn't rule out DKA. Symptomatic? Check ketones and blood glucose.
Transport: A urine dip doesn't replace a fingerstick. Altered, diaphoretic or seizing? Check blood glucose right away and treat per protocol.
Nursing: When glucosuria is expected on an SGLT2 inhibitor, record fluid intake and orthostatic symptoms. Osmotic diuresis can add to volume loss, especially in older adults.
Renal glucosuria is benign: Isolated glucosuria with consistently normal serum glucose and normal tubular markers needs no treatment. Still, check serum glucose from time to time.
Vitamin C: High-dose vitamin C can give a false negative on some strips. If you still suspect hyperglycemia, check serum glucose and write down the strip brand.
References
- American Diabetes Association Professional Practice Committee. (2026). 2. Diagnosis and Classification of Diabetes: Standards of Care in Diabetes—2026. Diabetes Care, 49(Suppl 1), S27–S49. https://doi.org/10.2337/dc26-S002
- American Diabetes Association and European Association for the Study of Diabetes. (2024). Hyperglycemic Crises in Adults With Diabetes: A Consensus Report. Diabetes Care, 47(8), 1257–1275. https://doi.org/10.2337/dci24-0032
- JARDIANCE (empagliflozin) tablets, US prescribing information. Boehringer Ingelheim. Revised 1/2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=faf3dd6a-9cd0-39c2-0d2e-232cb3f67565
- Torun Bayram M, Kavukcu S. (2025). Renal glucosuria in children. World Journal of Clinical Pediatrics, 14(1), 91622. doi:10.5409/wjcp.v14.i1.91622. https://wjgnet.com/2219-2808/full/v14/i1/91622.htm
- Unic A, Nikolac Gabaj N, Miler M, Culej J, Lisac A, Horvat A, Vrkic N. (2018). Ascorbic acid—A black hole of urine chemistry screening. Journal of Clinical Laboratory Analysis, 32(5), e22390. https://pmc.ncbi.nlm.nih.gov/articles/PMC6816895/
- INPEFA (sotagliflozin) tablets, US prescribing information. Lexicon Pharmaceuticals. Revised 8/2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=1a46614e-05f6-421a-b6f4-d6f8760d643a
- BRENZAVVY (bexagliflozin) tablets, US prescribing information. TheracosBio. Revised 6/2026. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=3cdf28fc-4194-4ad6-aa03-c9eaa68da83e
- IFEX (ifosfamide) injection, US prescribing information. Baxter Healthcare Corporation. Revised 12/2024. Section 5.3 (nephrotoxicity, including Fanconi syndrome). https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=b7241707-7538-4d1a-91e7-3a25a91e0b9a
Medical Disclaimer
- For Educational Purposes Only: This content is intended for educational reference and should not be used for clinical decision-making.
- Not a Substitute for Professional Judgment: Always consult your local protocols, institutional guidelines, and supervising physicians.
- Verify Before Acting: Users are responsible for verifying information through authoritative sources before any clinical application.
AI Assistance Notice
AI was used to assist in organizing, paraphrasing, and formatting this information.